A vitiligo consultation can help you understand what type of vitiligo you have, whether it is active and which treatments may suit you. You can also ask whether your skin colour may return, what could have triggered the patches and what changes you might expect.
Your specialist may look at where the patches are, how quickly they developed and which treatments you have already tried. Preparing a few questions can help you understand your diagnosis, treatment choices and what to expect next.
How Can Your Dermatologist Confirm Your Vitiligo Diagnosis?
If this is your first specialist appointment, you can ask how certain your dermatologist is that you have vitiligo. Not every pale or white patch is caused by vitiligo, as fungal infections, inflammatory skin conditions and post-inflammatory hypopigmentation can also affect skin colour. Your dermatologist may examine the pattern and development of the patches and use a Wood’s lamp to make subtle pigment loss easier to see.
You can also ask what other conditions have been considered and whether you need any further tests. Most straightforward cases can be diagnosed through a clinical examination, so you may not need a biopsy or complicated investigations. Getting the diagnosis right helps ensure that the treatment you receive is suitable for your skin condition.
What Type of Vitiligo Do You Have?
Vitiligo can follow different patterns. Your dermatologist can explain whether you have non-segmental, segmental, acrofacial or mucosal vitiligo, based on where your patches appear and how they developed.
You can ask during your consultation whether your type affects treatment or likely progression. Recording the pattern helps your dermatologist plan care and gives you information that is more relevant to your individual condition and treatment choices.
Is Your Vitiligo Active or Stable?
You can ask whether your vitiligo is active or stable, as this can affect your treatment plan. Active vitiligo means new patches are appearing or existing ones are spreading, while stable vitiligo has remained unchanged. Your dermatologist may ask whether you have noticed changes over the past year and may compare photographs taken at different times.
Knowing whether your condition is stable can help you understand which treatments may be suitable for you. British Association of Dermatologists guidance uses 12 months without new or progressing lesions when assessing stability, although this can sometimes be difficult to judge. Stability is particularly important if you are considering surgical treatments, which are generally used when vitiligo is stable.
Evidence Note
British Association of Dermatologists guidance notes that overall vitiligo stability can sometimes be difficult to judge and that the stability of an individual lesion may be more reliable. Serial photographs and recognised assessment tools can help your dermatologist document whether a particular patch has changed over time.
This can be especially useful when treatment decisions depend on documented stability rather than memory alone.
How Much of Your Skin Is Affected?
You may have an idea of how much skin is affected, but your dermatologist can assess it more accurately. The extent of vitiligo can influence treatment choices, with smaller areas sometimes treated with topical or targeted options, while more extensive disease may involve phototherapy.
You can ask how your affected skin area will be recorded and how changes will be measured over time. Tools such as the Vitiligo Extent Score and Vitiligo Area Scoring Index may help monitor pigment loss. Having a clear starting point can help you and your dermatologist see whether treatment is working or the condition is progressing.
Do You Need Any Blood Tests or Other Investigations?
You can ask whether you need any blood tests, particularly because vitiligo can occur alongside other autoimmune conditions. Thyroid problems are a recognised association, and British Association of Dermatologists guidance recommends screening thyroid function and antithyroid antibodies in people with vitiligo. You should also mention any symptoms or relevant family history that may help with your assessment.
Not everyone with vitiligo needs a large number of investigations, so ask what each test is intended to check. Your medical history and symptoms can help your dermatologist decide whether further testing is appropriate for you and whether any previous blood results are enough.
UK Guidance Note
British Association of Dermatologists guidance recommends thyroid function and antithyroid antibody screening in people with vitiligo, including children. The aim is to identify people who may be at higher risk of autoimmune thyroid disease.
You can ask which tests are being arranged, how you will receive the results and whether an abnormal result would need follow-up with your GP or another specialist.
Why Might Your Vitiligo Have Developed?
There may not be one clear reason why you developed vitiligo. It is an autoimmune condition in which the immune system targets melanocytes, the cells that produce pigment. You can ask whether your family history, genetics or other factors may be relevant.
Tell your dermatologist if patches appeared after sunburn or skin injury, as some people develop vitiligo at sites of trauma through the Koebner phenomenon. This can help you understand your pattern and plan treatment.
Which Areas of Your Vitiligo Are Most Likely to Repigment?
You can ask which areas of your vitiligo are most likely to respond to treatment, as different parts of the body can respond differently. The face and neck often respond well, while areas such as the fingertips and toes can be more difficult to repigment. Your dermatologist can discuss the likely response for each affected area rather than giving you one general prediction.
You should also ask whether the hair within your patches could affect repigmentation. Areas with pigmented hair follicles may have a better potential for colour return than areas with completely white hairs. Understanding these differences can help you know what improvement you might realistically expect from treatment.
Factors That May Affect Treatment Response
| Factor | Why it matters |
| Face and neck | Often respond better to repigmentation treatment |
| Hands, fingers and feet | Usually more resistant |
| Pigmented hairs in a patch | May indicate remaining follicular pigment-cell reservoirs |
| White hairs within the patch | Can be associated with a poorer response |
| Active vitiligo | Initial treatment may focus on controlling progression |
| Stable vitiligo | Some additional options, including selected surgical treatments, may be considered |
| Previous treatment response | Helps guide whether treatment should be continued or changed |
What Is the Main Goal of Treatment in Your Case?
Treatment goals can be different for everyone, so you can ask what your dermatologist considers realistic for you. If your vitiligo is active, the priority may be to slow new patches or prevent existing areas from spreading. If it is stable, the focus may shift towards restoring lost skin colour.
You can also discuss whether partial repigmentation would be worthwhile and whether some areas may be harder to treat. There is no single treatment that suits everyone, so understanding your options and priorities can help you decide what you want from treatment.
Which Treatment Options Are Appropriate for You?
You can ask which treatments are suitable for you based on your type, location and extent of vitiligo. Options may include topical corticosteroids, tacrolimus, narrowband UVB phototherapy or, in selected stable cases, surgical treatments.
Your dermatologist can explain why a particular option may suit you and what results you could expect. In England, NICE recommends ruxolitinib cream as an option for people aged 12 and over with non-segmental vitiligo with facial involvement when topical first-line treatments have not worked or are unsuitable.
Research Insight
Two phase 3 trials involving 674 people aged 12 and over with non-segmental vitiligo found that around 30% of those using ruxolitinib cream achieved at least a 75% improvement in facial vitiligo scores after 24 weeks. In the two vehicle-cream groups, the corresponding figures were 7.4% and 11.4%.
These results do not mean everyone will respond in the same way. The trials included people with non-segmental vitiligo affecting no more than 10% of total body surface area, and the researchers noted that larger and longer studies were needed to understand longer-term effects and safety.
Why Might This Treatment Be Recommended for You?
You can ask why a particular treatment is being recommended for you. Your dermatologist may consider the location and extent of your vitiligo, your age, whether it is active, your previous treatments and how your skin has responded.
You should also ask whether there are suitable alternatives and why they may not be recommended for you at this stage. Your dermatologist can explain how factors such as body site, disease activity, previous treatment response, possible side effects and practical demands affect the choice. Understanding the reason behind the recommendation can help you feel more confident about the plan.
How Long Might You Need Treatment Before Results Become Clear?
Vitiligo treatment usually takes time, so you should ask when your dermatologist expects you to notice the first signs of improvement. Repigmentation happens gradually, and the timeframe can vary depending on the treatment and the areas being treated.
You can also ask when your progress will be reviewed and what would happen if the treatment is not working. For ruxolitinib cream, treatment discontinuation should be considered if there is less than 25% repigmentation in the treated areas after 52 weeks. Knowing the expected timeline can help you understand what to expect from treatment.
What Side Effects or Practical Problems Should You Expect?
You can ask which side effects are most relevant to your treatment. Topical steroids can thin the skin if overused, tacrolimus may cause temporary burning or irritation, and NB-UVB can cause redness, dryness or a sunburn-like reaction.
You should also consider practical demands. If you need frequent phototherapy visits, ask whether the schedule will realistically fit around work, school or caring responsibilities so you can choose a treatment you are able to follow consistently.
How Will Your Vitiligo Be Monitored?
You can ask how your vitiligo will be monitored during treatment. Your dermatologist may use photographs or tools such as VASI and the Vitiligo Extent Score to track changes over time. Taking consistent photos can help you see genuine repigmentation rather than changes caused by lighting or tanning.
You should also ask what signs of improvement to look for and how often your progress will be reviewed. Small areas of colour around hair follicles or along the edges of patches may indicate repigmentation, while new or spreading patches can suggest that your vitiligo is still active.
Clinical Tip
Ask whether baseline medical photographs will be taken before you start treatment and when they will be repeated. British dermatology guidance recommends photography at the start of treatment and at regular intervals of around three to six months to monitor response or progression.
If formal medical photography is not available, you can use your own device to photograph the same areas between appointments. This can give you and your dermatologist a more consistent record to compare over time.
What Should You Do Between Appointments?
Following your treatment plan consistently can help your dermatologist assess whether your vitiligo is improving. You should also protect your skin and note any important changes between visits.
- Use treatment as prescribed: Follow the instructions for how often and where to apply your medication.
- Protect your skin from the sun: When affected skin is exposed, use SPF 50 sunscreen with a 4-or 5-star UVA rating on the patches and surrounding skin.
- Avoid unnecessary skin trauma: Try to reduce repeated friction or injury, particularly if you experience the Koebner phenomenon.
- Track any changes: Note new or enlarging patches and consider taking consistent photographs to discuss at your next appointment.
If you use moisturisers, camouflage products or self-tanner, ask how they fit alongside your treatment. Keeping a simple record of changes can also make follow-up appointments more useful.
What Happens If the First Treatment Does Not Work?
You can ask what the next step would be if your first treatment does not give enough improvement. Your dermatologist may adjust the treatment, combine it with another option or suggest a different approach. A poor response to one treatment does not necessarily mean other options will not help.
You should also ask whether further treatment is worthwhile for you. In selected cases, cellular grafting may be considered when your vitiligo is stable, other treatments have not worked and the condition continues to cause you distress. You can also choose options such as camouflage makeup or self-tanner if they suit you.
What Should You Ask About Long-Term Outlook and Follow-Up?
You can ask how your vitiligo may behave over time and whether your dermatologist considers it stable or changing. You should also ask whether repigmentation is likely to last, how often you need follow-up and what changes should prompt an earlier review.
You can mention if vitiligo is affecting your confidence or quality of life, as emotional wellbeing is also part of care. Your dermatologist can help you understand what to expect, when to return and what support may be available if the condition is causing you distress.
Myth vs Fact
| Myth | Fact |
| Every person with vitiligo needs extensive blood tests. | Testing should be clinically appropriate, although thyroid screening is specifically recommended in UK dermatology guidance. |
| Stable vitiligo means it can never spread again. | Stability describes a period without progression; future activity can still occur. |
| Treatment should produce results within a few weeks. | Repigmentation commonly takes months and varies by treatment and body site. |
| One treatment works equally well everywhere. | Facial areas often respond better than hands and feet. |
| Surgery can be used while vitiligo is actively spreading. | Surgical treatment is generally reserved for carefully selected stable disease. |
| Treatment guarantees complete repigmentation. | Response varies and complete colour restoration cannot be guaranteed. |
Key Takeaways
- Confirm that the diagnosis is vitiligo and understand which type you have.
- Ask whether your vitiligo is active or stable, as this can affect treatment choices.
- Treatment response varies by body area, with the face often responding better than hands and feet.
- British dermatology guidance recommends thyroid function and antithyroid antibody screening because vitiligo is associated with autoimmune thyroid disease.
- Treatment usually takes time, and repigmentation can develop gradually over several months.
- Ask how your progress will be monitored and when treatment should be reviewed.
- Not every treatment works for every person, so alternatives may be considered if the first option is not effective.
- Complete repigmentation cannot be guaranteed, and long-term follow-up may still be useful even after improvement.
Frequently Asked Questions
1. What Helps Your Dermatologist Distinguish Vitiligo From Other Skin Conditions?
Your dermatologist can usually diagnose vitiligo by examining your skin and reviewing how your patches developed. A Wood’s lamp may help your dermatologist identify subtle pigment loss and distinguish your vitiligo from other causes of pale or white patches.
2. How Can Your Vitiligo Type Affect Treatment Choices?
Your dermatologist can explain whether you have non-segmental, segmental, acrofacial or mucosal vitiligo. The pattern and areas affected can influence your treatment plan. Knowing your type can also help you understand how the condition may develop.
3. Why Does Vitiligo Stability Matter for Your Treatment Plan?
If your vitiligo is active, you may notice new patches or existing areas becoming larger. Your dermatologist may compare your photographs over time, because knowing whether your vitiligo is stable can affect treatment choices, particularly if surgery is being considered.
4. Why Might Thyroid Tests Be Discussed During Your Vitiligo Assessment?
Your dermatologist may discuss thyroid testing because vitiligo can be associated with autoimmune thyroid disease. You may be offered thyroid function and antithyroid antibody tests, with your symptoms, medical history and family history helping guide any further investigations.
5. Why Do Some Areas of Vitiligo Respond Better Than Others?
You may find that different areas of your vitiligo respond differently to treatment. Your face and neck often have better repigmentation potential, while your fingertips and toes can be harder to treat. The colour of hair within your affected areas may also influence your response.
6. What Treatments Are Available for Vitiligo?
Your treatment options may include topical corticosteroids, tacrolimus, narrowband UVB phototherapy and, in selected stable cases, surgery. You may also be eligible for ruxolitinib cream depending on your age, type of vitiligo, facial involvement and previous treatment response.
7. What Factors Influence Which Vitiligo Treatment Is Chosen for You?
Your treatment choice may depend on the type, location and extent of your vitiligo, as well as whether it is active or stable. Previous treatments and your response to them can also influence the decision. You can ask about alternatives and why they may not be suitable.
8. When Might You Notice Early Signs of Repigmentation?
Repigmentation usually happens gradually, and the timeframe varies between treatments and affected areas. You can ask when early improvement should appear and when your progress will be reviewed. If the treatment is not working sufficiently, your dermatologist can discuss the next step.
9. How Can Photographs and Scoring Tools Track Your Vitiligo?
Your dermatologist may use photographs and scoring tools such as VASI or the Vitiligo Extent Score to monitor your condition. You can also track your progress with consistent photographs and ask which changes suggest improvement or continuing activity.
10. What Other Options Can You Consider If Your First Treatment Is Not Effective?
Your dermatologist may adjust the treatment, combine different options or recommend another approach. Cellular grafting may be considered in selected cases when your vitiligo is stable, other treatments have not worked and the condition continues to cause you distress. Camouflage makeup or self-tanner can also help reduce the appearance of patches.
Final Thoughts: Preparing for Your Vitiligo Consultation
A vitiligo consultation gives you an opportunity to understand your diagnosis, whether your condition is active or stable, and which treatment options may be suitable. Preparing questions about expected results, side effects, monitoring and long-term care can help you make informed decisions about your treatment.
If you are considering Vitiligo treatment in London, you can contact the London Dermatology Centre to discuss your condition and arrange a consultation with one of our specialists.
References:
- Eleftheriadou, V. et al. (2022) ‘British Association of Dermatologists guidelines for the management of people with vitiligo 2021’, British Journal of Dermatology, 186(1), pp. 18–29. Available at: https://academic.oup.com/bjd/article/186/1/18/6593593
- Abdi, P. et al. (2023) ‘Non-invasive skin measurement methods and diagnostics for vitiligo: a systematic review’, Frontiers in Medicine, 10, 1200963. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10416110/
- Rosmarin, D. et al. (2022) ‘Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo’, New England Journal of Medicine, 387(16), pp. 1445–1455. Available at: https://pubmed.ncbi.nlm.nih.gov/36260792/
- National Institute for Health and Care Excellence (NICE) (2026) Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and over. Technology appraisal guidance TA1140. Available at: https://www.nice.org.uk/guidance/ta1140
- Iamsumang, W. et al. (2026) ‘Leukotrichia: A comprehensive review of follicular depigmentation’, Journal of International Medical Research, 54(9), 03000605261483177. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC13535012/